Remedent Announces Exclusive Agreement With Biotech Medical Aesthetic SAS in Reference to Its Product River 8
Remedent, Inc. (OTCBB: REMI), an international company specializing in research, development, and manufacturing of oral care and cosmetic dentistry products, announces its exclusive agreement with Biotech Medical Aesthetic SAS for distributing its River 8 veneers worldwide.
River 8 -- the revolutionary, painless, and affordable porcelain veneer solution for discolored, damaged, stained or misaligned teeth -- will be produced by Remedent and globally distributed by Biotech International who are already active in over 40 countries as market leader in dental and orthopedic surgery implants.
Both partners have agreed upon a renewable 5 years contract with a first order of 1 million euros (1,35 million USD).
Management Commentary:"We are very excited about this partnership," comments Mr. Guy De Vreese, CEO of Remedent. "The River 8 concept and technology is going to radically transform cosmetic dentistry worldwide, achieving a whitening result that lasts without bleaching."
Mr. Philippe Veran, CEO of Biotech, adds: "This cooperation fits perfectly in our vision: we believe cosmetic solutions in general and veneers in particular will have their undisputed place in every dental practice of tomorrow."
Remedent Inc. creates state-of-the-art dental technologies and marketing concepts. Famous brands are GlamSmile, Remecure, White Boost, Formulation +, and River 8. Headquartered in Belgium, Remedent Inc. manufactures, markets and distributes its products and concepts to more than 25 countries worldwide. Remedent Inc. is publicly listed and focuses on B2B, delivering products to the dental professional, as well as B2C approaches, helping consumers to obtain their dream smile through its Smile Consultancy Concept.